Novabay Pharmaceuticals Inc Current ratio
Quel est le Current ratio de Novabay Pharmaceuticals Inc?
Le Current ratio de Novabay Pharmaceuticals Inc est 0.62
Quelle est la définition de Current ratio?
Le ratio actuel est un ratio de liquidité qui mesure si une entreprise dispose ou non de ressources suffisantes pour faire face à ses obligations à court terme.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio des entreprises dans Health Care secteur sur NYSEMKT par rapport à Novabay Pharmaceuticals Inc
Que fait Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Entreprises avec current ratio similaire à Novabay Pharmaceuticals Inc
- Axis Capital Ltd a Current ratio de 0.62
- Paragon GmbH & Co. KGaA a Current ratio de 0.62
- Berry Corp a Current ratio de 0.62
- AJ Lucas a Current ratio de 0.62
- Entergy Utility Enterprises Inc a Current ratio de 0.62
- Guoan International a Current ratio de 0.62
- Novabay Pharmaceuticals Inc a Current ratio de 0.62
- Brookfield Business a Current ratio de 0.63
- Cracker Barrel Old Country Store Inc a Current ratio de 0.63
- Tingyi (Cayman Islands) a Current ratio de 0.63
- China Dredging Environment Protection a Current ratio de 0.63
- Verizon Communications Inc a Current ratio de 0.63
- Target Capital a Current ratio de 0.63